Luma Fertility Company Profile

Background

Luma Fertility, established in 2024 by Neha K. Motwani, is a Mumbai-based fertility-tech startup dedicated to transforming reproductive healthcare in India. Motivated by her personal fertility journey, Motwani identified significant gaps in the existing system, including a lack of support, clarity, and compassion. Luma Fertility's mission is to provide patient-centric, tech-enabled fertility care that prioritizes empathy and innovation.

Key Strategic Focus

Luma Fertility's strategic objectives include:

Comprehensive Fertility Services: Offering a full spectrum of services such as in-vitro fertilization (IVF), egg and embryo freezing, fertility assessments, and pre-conception consultations.

Holistic Patient Care: Integrating services like nutrition counseling, acupuncture, IV therapy, and at-home semen analysis to support both physical and emotional well-being.

Technological Integration: Utilizing advanced technologies, including AI-driven tools, to enhance patient engagement and treatment outcomes.

Market Expansion: Initially focusing on Mumbai, with plans to extend services to other major Indian cities over the next two years.

Financials and Funding

In July 2025, Luma Fertility secured $4 million in seed funding led by Peak XV’s Surge, with participation from Ameera Shah (Metropolis Healthcare) and Vijay Taparia (B2V Ventures). The capital is earmarked for expanding the company's presence in Mumbai and other cities, enhancing technological capabilities, and improving patient care services.

Technological Platform and Innovation

Luma Fertility distinguishes itself through several proprietary technologies and innovative methodologies:

LumaAI: An AI-enabled tool providing 24/7, jargon-free support for cycle timelines, medication guidance, and patient queries.

Integrated Mobile Application: Allows patients to track their treatment journey, access reports, and receive real-time updates, fostering transparency and engagement.

Advanced Embryology Lab: Equipped with state-of-the-art incubators and micromanipulation tools, ensuring optimal conditions for embryo development.

AI-Driven Embryo Selection: Utilizes artificial intelligence to analyze and select the most viable embryos, enhancing success rates.

RI Witness System: Employs RFID technology to track and monitor all gametes and embryos, ensuring sample accuracy and preventing mix-ups.

Leadership Team

Neha K. Motwani: Founder – Previously founded Fitternity, India's largest fitness marketplace, acquired by CureFit in 2021. Her personal fertility experiences inspired the creation of Luma Fertility.

Dr. Radhika Sheth: Medical Director – With over 18 years of experience in fertility and reproductive medicine, she has trained in ART across Germany, the UK, and Italy.

Dr. Vishesha Yadav: Senior Consultant – Fertility and IVF – A double board-certified gynecologist and fertility specialist with over 8 years of experience, known for her personalized approach.

Dr. Parzan Mistry: Principal Consultant – IVF – With over 11 years of experience, he specializes in fertility and high-risk obstetrics in Mumbai.

Chirag Shah: Chief Embryologist – An internationally trained embryologist with over 10 years of experience, having performed over 10,000 ICSI cycles.

Apoorva Joshi: President – Strategy & Care Management – Brings over 13 years of experience in women's health, healthcare consulting, and corporate wellness.

Dr. Kanwarpal S. Selhi: Head – Strategy & Business – With over 5 years of experience in healthcare, pharmaceuticals, and finance, he has executed numerous deals and contributed to significant AUM growth.

Preeta Sukhtankar: Strategic Advisor – With over 20 years in the entertainment and lifestyle space, she has founded and led direct-to-consumer ventures and now advises female-led businesses.

Competitor Profile

Market Insights and Dynamics

The global fertility services market is projected to reach $53 billion by 2030, driven by factors such as delayed parenthood, increasing age-related infertility, and declining global fertility rates. In India, the total fertility rate has fallen below the replacement level, declining from 2.1 to 1.9 births per woman. Over 33 million couples in the country face fertility challenges, with IVF cycles expected to grow from 320,000 in 2024 to 550,000 by 2028.

Competitor Analysis

Key competitors in the Indian fertility services market include:

Nova IVF Fertility: Offers a range of fertility treatments with a focus on transparency and patient-centric care.

Cloudnine Fertility: Provides comprehensive fertility services with an emphasis on advanced technology and personalized treatment plans.

Indira IVF: Known for its extensive network of clinics and affordable treatment options, making fertility care accessible to a broader population.

Strategic Collaborations and Partnerships

Luma Fertility has secured strategic investments from notable healthcare leaders:

Ameera Shah: Promoter & Executive Chairperson of Metropolis Healthcare, bringing deep domain expertise and strategic insight.

Vijay Taparia: Chairman of B2V Ventures, providing credibility and support for Luma's growth potential.

Operational Insights

Luma Fertility's patient-first and outcome-driven approach, combined with its tech-enabled services, positions it as a significant player in the Indian fertility market. The company's commitment to transparency, empathy, and innovation differentiates it from competitors and aligns with the growing demand for modern, accessible fertility care.

Strategic Opportunities and Future Directions

With the recent funding, Luma Fertility plans to:

Expand Clinic Footprint: Increase its presence in Mumbai and enter new cities such as Bengaluru, Hyderabad, Pune, and Delhi over the next two years.

Enhance Technological Capabilities: Invest in proprietary technology to improve patient engagement and treatment outcomes.

Broaden Service Offerings: Focus on expanding egg and embryo preservation services to cater to urban millennials and Gen Z individuals delaying parenthood.